Market Overview:
The global melanoma scanner market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of melanoma, rising awareness about early detection and diagnosis of melanoma, and technological advancements in melanoma scanners. Based on type, the global melanoma scanner market is segmented into superficial spreading melanoma, nodular melanoma, lentigo maligna, and acral lentiginous melanoma. Superficial spreading melonama is expected to account for the largest share of the global market in 2018 owing to its high incidence rate. Based on application, the hospital segment is expected to account for the largest share of the global market in 2018 owing to increasing demand for early diagnosis and treatment of cancer patients.
Product Definition:
A melanoma scanner is a device that is used to detect melanoma, which is a type of skin cancer. The scanner uses light waves to create an image of the skin that can be used to identify any areas that may be affected by melanoma. The use of a melanoma scanner can help to ensure early detection and treatment of the disease.
Superficial Spreading Melanoma:
Superficial spreading melanoma is a type of skin cancer that occurs when the pigment-producing cells in the skin (melanin) spread to other parts of the body. The condition is most commonly found in people with fair skin, but it can also occur in those with dark or light skin who have severe sun damage. Superficial spreading melanoma accounts for less than 5% of all cases of melanoma and less than 10%of all cancers diagnosed worldwide.
Nodular Melanoma:
Nodular melanoma is a type of malignant tumor that develops in the pigment-producing cells of the skin. These nodules may be present from birth or can appear during any particular age. The most common sites for these tumors are behind the ear, under the arm, and on the face (nose, lip).
Application Insights:
The market is segmented into hospital, clinic, research institute and others. The hospital application segment dominated the overall market in 2017 owing to increasing prevalence of cancer across the globe. According to WHO, around 1 in 6 deaths occur due to cancer which accounts for 2 million deaths every year globally. Rising awareness about skin cancer among individuals as well as healthcare professionals coupled with rising availability of advanced treatment facilities is anticipated to boost product demand over the forecast period.
Clinic application segment is expected register a significant CAGR during the study period owing to growing awareness about early detection and treatment of melanoma among individuals as well as dermatologists/oncologists at clinics and hospitals worldwide. Increasing number of clinics offering cosmetic surgeries along with rising adoption of MELAFIND devices by these centers for better detection rate are factors anticipated drive growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of melanoma patients, increasing adoption of technologically advanced medical products and rising government initiatives. For instance, in May 2018, U.S FDA approved Melvita Melatonin CRT System for use by physicians for treating adult patients with cutaneous melanoma who have already received at least one prior systemic therapy or are ineligible for immunotherapy or targeted therapy (U.S).
Asia Pacific is expected to witness lucrative growth over the forecast period owing to an increase in disposable income coupled with growing awareness about early diagnosis and treatment options among people affected with malignant tumors such as melanoma across countries such as India & China & Japan etc., which will boost product demand during the forecast period (2018-2030).
Growth Factors:
- Increasing incidence of melanoma
- Growing awareness about the early detection of melanoma
- Rising demand for minimally invasive diagnostic procedures
- Technological advancements in melanoma scanners
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Melanoma Scanner Market Research Report
By Type
Superficial Spreading Melanoma, Nodular Melanoma, Lentigo Maligna, Acral Lentiginous Melanoma
By Application
Hospital, Clinic, Research Institute, Others
By Companies
Strata Skin Sciences, Verisante, MedX Health, Abbott Laboratory, Medtronic, Siemens AG, Baxter International Inc., Agilent Technology, Roche, AstraZeneca, Strata Skin Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Melanoma Scanner Market Report Segments:
The global Melanoma Scanner market is segmented on the basis of:
Types
Superficial Spreading Melanoma, Nodular Melanoma, Lentigo Maligna, Acral Lentiginous Melanoma
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Research Institute, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Strata Skin Sciences
- Verisante
- MedX Health
- Abbott Laboratory
- Medtronic
- Siemens AG
- Baxter International Inc.
- Agilent Technology
- Roche
- AstraZeneca
- Strata Skin Sciences
Highlights of The Melanoma Scanner Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Superficial Spreading Melanoma
- Nodular Melanoma
- Lentigo Maligna
- Acral Lentiginous Melanoma
- By Application:
- Hospital
- Clinic
- Research Institute
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Melanoma Scanner Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A melanoma scanner is a medical device that uses X-rays to detect the presence of melanomas. Melanomas are skin cancers that can be deadly if not detected and treated early.
Some of the key players operating in the melanoma scanner market are Strata Skin Sciences, Verisante, MedX Health, Abbott Laboratory, Medtronic, Siemens AG, Baxter International Inc., Agilent Technology, Roche, AstraZeneca, Strata Skin Sciences.
The melanoma scanner market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Melanoma Scanner Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Melanoma Scanner Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Melanoma Scanner Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Melanoma Scanner Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Melanoma Scanner Market Size & Forecast, 2018-2028
4.5.1 Melanoma Scanner Market Size and Y-o-Y Growth
4.5.2 Melanoma Scanner Market Absolute $ Opportunity
Chapter 5 Global Melanoma Scanner Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Melanoma Scanner Market Size Forecast by Type
5.2.1 Superficial Spreading Melanoma
5.2.2 Nodular Melanoma
5.2.3 Lentigo Maligna
5.2.4 Acral Lentiginous Melanoma
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Melanoma Scanner Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Melanoma Scanner Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Research Institute
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Melanoma Scanner Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Melanoma Scanner Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Melanoma Scanner Analysis and Forecast
9.1 Introduction
9.2 North America Melanoma Scanner Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Melanoma Scanner Market Size Forecast by Type
9.6.1 Superficial Spreading Melanoma
9.6.2 Nodular Melanoma
9.6.3 Lentigo Maligna
9.6.4 Acral Lentiginous Melanoma
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Melanoma Scanner Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Research Institute
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Melanoma Scanner Analysis and Forecast
10.1 Introduction
10.2 Europe Melanoma Scanner Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Melanoma Scanner Market Size Forecast by Type
10.6.1 Superficial Spreading Melanoma
10.6.2 Nodular Melanoma
10.6.3 Lentigo Maligna
10.6.4 Acral Lentiginous Melanoma
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Melanoma Scanner Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Research Institute
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Melanoma Scanner Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Melanoma Scanner Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Melanoma Scanner Market Size Forecast by Type
11.6.1 Superficial Spreading Melanoma
11.6.2 Nodular Melanoma
11.6.3 Lentigo Maligna
11.6.4 Acral Lentiginous Melanoma
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Melanoma Scanner Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Research Institute
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Melanoma Scanner Analysis and Forecast
12.1 Introduction
12.2 Latin America Melanoma Scanner Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Melanoma Scanner Market Size Forecast by Type
12.6.1 Superficial Spreading Melanoma
12.6.2 Nodular Melanoma
12.6.3 Lentigo Maligna
12.6.4 Acral Lentiginous Melanoma
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Melanoma Scanner Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Research Institute
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Melanoma Scanner Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Melanoma Scanner Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Melanoma Scanner Market Size Forecast by Type
13.6.1 Superficial Spreading Melanoma
13.6.2 Nodular Melanoma
13.6.3 Lentigo Maligna
13.6.4 Acral Lentiginous Melanoma
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Melanoma Scanner Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Research Institute
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Melanoma Scanner Market: Competitive Dashboard
14.2 Global Melanoma Scanner Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Strata Skin Sciences
14.3.2 Verisante
14.3.3 MedX Health
14.3.4 Abbott Laboratory
14.3.5 Medtronic
14.3.6 Siemens AG
14.3.7 Baxter International Inc.
14.3.8 Agilent Technology
14.3.9 Roche
14.3.10 AstraZeneca
14.3.11 Strata Skin Sciences
